-
公开(公告)号：EP4104867A3
公开(公告)日：2023-03-01
申请号：EP22166699.3
申请日：2016-12-14
发明人： AZNAREZ, Isabel , NASH, Huw M. , KRAINER, Adrian
IPC分类号： A61K48/00 , C12N15/113 , C12Q1/68
摘要： Provided herein are methods and compositions for increasing the expression of ATP1A2, CACNA1A, SETD5, SHANK3, NF2, DNMT1, TCF4, RAI1, PEX1, ARSA, EIF2B5, EIF2B1, EIF2B2, NPC1, ADAR, MFSD8, STXBP1, PRICKLE2, PRRT2, IDUA, or STX1B, and for treating a subject in need thereof, e.g., a subject with deficient ATP1A2, CACNA1A, SETD5, SHANK3, NF2, DNMT1, TCF4, RAI1, PEX1, ARSA, EIF2B5, EIF2B1, EIF2B2, NPC1, ADAR, MFSD8, STXBP1, PRICKLE2, PRRT2, IDUA, or STX1B protein expression.
-
公开(公告)号：EP3690048A1
公开(公告)日：2020-08-05
申请号：EP19206009.3
申请日：2014-09-04
IPC分类号： C12N15/113 , A61K31/7088
摘要： The present disclosure relates to compositions and methods for inhibiting nonsense-mediated mRNA decay in a gene-specific manner, for example in the treatment of diseases or disorders caused by nonsense mutations.
-
公开(公告)号：EP3390635A1
公开(公告)日：2018-10-24
申请号：EP16876615.2
申请日：2016-12-14
发明人： AZNAREZ, Isabel , NASH, Huw M.
IPC分类号： C12N15/113 , C12Q1/68
CPC分类号： C12Q1/6883 , A61K31/7088 , C12N15/1135 , C12N2310/11 , C12Q2600/156 , C12Q2600/178
摘要： Provided herein are methods and compositions for increasing the expression of TSC2, and for treating a subject in need thereof, such as a subject with deficient tuberin protein expression or a subject having tuberous sclerosis complex.
-
公开(公告)号：EP3389671A1
公开(公告)日：2018-10-24
申请号：EP16876499.1
申请日：2016-12-13
发明人： AZNAREZ, Isabel , NASH, Huw M.
IPC分类号： A61K31/7088 , C12N15/11 , C12N15/113 , C12Q1/68
CPC分类号： A61K31/7088 , C12N15/111 , C12N15/113 , C12N2310/315 , C12N2310/321 , C12N2320/33 , C12Q1/68 , C12Q1/6883 , C12Q2600/156 , C12N2310/3521
摘要： Provided herein are methods and compositions for increasing the expression of JAGl, and for treating a subject in need thereof, e.g., a subject with deficient JAGl protein expression or a subject having Alagille syndrome (ALGS).
-
公开(公告)号：EP4104867A2
公开(公告)日：2022-12-21
申请号：EP22166699.3
申请日：2016-12-14
发明人： AZNAREZ, Isabel , NASH, Huw M. , KRAINER, Adrian
IPC分类号： A61K48/00 , C12N15/113 , C12Q1/68
摘要： Provided herein are methods and compositions for increasing the expression of ATP1A2, CACNA1A, SETD5, SHANK3, NF2, DNMT1, TCF4, RAI1, PEX1, ARSA, EIF2B5, EIF2B1, EIF2B2, NPC1, ADAR, MFSD8, STXBP1, PRICKLE2, PRRT2, IDUA, or STX1B, and for treating a subject in need thereof, e.g., a subject with deficient ATP1A2, CACNA1A, SETD5, SHANK3, NF2, DNMT1, TCF4, RAI1, PEX1, ARSA, EIF2B5, EIF2B1, EIF2B2, NPC1, ADAR, MFSD8, STXBP1, PRICKLE2, PRRT2, IDUA, or STX1B protein expression.
-
公开(公告)号：EP3389672A1
公开(公告)日：2018-10-24
申请号：EP16876543.6
申请日：2016-12-14
发明人： AZNAREZ, Isabel , NASH, Huw M. , HALL, Samuel W. , JING, Enxuan
IPC分类号： A61K31/7088 , C12N15/113 , C12Q1/68
CPC分类号： A61K31/7088 , A61K31/712 , A61K31/7125 , C12N15/113 , C12N2310/11 , C12N2310/315 , C12N2310/346 , C12N2320/33 , C12N2310/321 , C12N2310/3521
摘要： Provided herein are methods and compositions for increasing the expression of a protein, and for treating a subject in need thereof, e.g., a subject with deficient protein expression or a subject having a liver disease.
-
公开(公告)号：EP3041958A1
公开(公告)日：2016-07-13
申请号：EP14842672.9
申请日：2014-09-04
IPC分类号： C12Q1/68 , C12N15/113 , A61K31/7088
CPC分类号： C12N15/111 , A61K31/4245 , A61K31/713 , A61K31/726 , C12N2310/11 , C12N2320/30 , C12N2320/31 , C12Q1/6883 , C12Q2600/106 , C12Q2600/156
摘要： The present disclosure relates to compositions and methods for inhibiting nonsense-mediated mRNA decay in a gene-specific manner, for example in the treatment of diseases or disorders caused by nonsense mutations.
-
公开(公告)号：EP3933041A1
公开(公告)日：2022-01-05
申请号：EP21167500.4
申请日：2016-12-14
发明人： AZNAREZ, Isabel , NASH, Huw M. , KRAINER, Adrian
IPC分类号： C12N15/113 , C12N15/11 , C12Q1/68 , A61K31/712 , A61K31/7125 , A61K31/713 , C12Q1/6883 , A61P43/00
摘要： Provided herein are methods and compositions for treating a subject in need thereof, such as a subject with deficient SYNGAP1 protein or SCN1A protein expression or a subject having AD mental retardation 5 or Dravet syndrome.
-
公开(公告)号：EP3390666A1
公开(公告)日：2018-10-24
申请号：EP16876548.5
申请日：2016-12-14
发明人： AZNAREZ, Isabel , NASH, Huw M.
IPC分类号： C12Q1/68 , C12N15/11 , C12N15/113 , C12N15/52
CPC分类号： C12N15/1138 , C12N15/111 , C12N2310/11 , C12N2310/315 , C12N2310/321 , C12N2320/33 , C12N2310/3521
摘要： Provided herein are methods and compositions for increasing the expression of a protein, and for treating a subject in need thereof, e.g., a subject with deficient protein expression or a subject having a kidney disease.
-
10.发明公开
公开(公告)号：EP3390636A1
公开(公告)日：2018-10-24
申请号：EP16876616.0
申请日：2016-12-14
发明人： AZNAREZ, Isabel , NASH, Huw M.
IPC分类号： C12N15/113 , C12N15/11 , C12Q1/68
CPC分类号： C12N15/1138 , A61K31/712 , A61K31/7125 , A61K31/713 , C12N2310/11 , C12N2310/315 , C12N2310/346 , C12N2320/33 , C12Q1/68 , C12Q1/6883 , C12Q2600/158 , C12N2310/321 , C12N2310/3521
摘要： Provided herein are methods and compositions for treating a subject in need thereof, such as a subject with deficient SYNGAP1 protein or SCN1A protein expression or a subject having AD mental retardation 5 or Dravet syndrome.
-
-
-
-
-
-
-
-
-
搜索结果
15 条记录 (耗时 0.018 秒)
